These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 8641653)
1. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor. La Nasa G; Pizzati A; Ledda A; Vacca A; Arras M; Contu L Haematologica; 1996; 81(2):178-81. PubMed ID: 8641653 [TBL] [Abstract][Full Text] [Related]
2. Unrelated donor BMT for Wiskott-Aldrich syndrome. Lenarsky C; Weinberg K; Kohn DB; Parkman R Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M; Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [TBL] [Abstract][Full Text] [Related]
4. Successful unrelated bone marrow transplantation in beta-thalassaemia. Contu L; La Nasa G; Arras M; Ledda A; Pizzati A; Vacca A; Carcassi C; Floris L; Porcella R; Orrù S Bone Marrow Transplant; 1994 Mar; 13(3):329-31. PubMed ID: 8199574 [TBL] [Abstract][Full Text] [Related]
5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
6. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Pai SY; DeMartiis D; Forino C; Cavagnini S; Lanfranchi A; Giliani S; Moratto D; Mazza C; Porta F; Imberti L; Notarangelo LD; Mazzolari E Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426 [TBL] [Abstract][Full Text] [Related]
7. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149 [TBL] [Abstract][Full Text] [Related]
9. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176 [TBL] [Abstract][Full Text] [Related]
10. [Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia]. Ji S; Chen H; Wang H Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):408-10. PubMed ID: 11718090 [TBL] [Abstract][Full Text] [Related]
11. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097 [TBL] [Abstract][Full Text] [Related]
12. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [TBL] [Abstract][Full Text] [Related]
13. Unrelated donor marrow transplantation for inborn errors. Miano M; Porta F; Locatelli F; Miniero R; La Nasa G; Di Bartolomeo P; Giardini C; Messina C; Balduzzi A; Testi AM; Garbarino L; Lanino E; Crescenzi F; Zecca M; Dini G Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S37-41. PubMed ID: 9630323 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [TBL] [Abstract][Full Text] [Related]
15. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289 [TBL] [Abstract][Full Text] [Related]
16. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience. Zwaan CM; Van Weel-Sipman MH; Fibbe WE; Oudshoorn M; Vossen JM Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036 [TBL] [Abstract][Full Text] [Related]
17. Ethics of using a bone marrow donor with Klinefelter syndrome. McGovern MM; Rhodes R Pediatr Transplant; 2008 Aug; 12(5):496-8. PubMed ID: 18537900 [No Abstract] [Full Text] [Related]
19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [TBL] [Abstract][Full Text] [Related]
20. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]